SRAX Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SRAX in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SRAX stock.
View analyst ratings for SRAX or view top-rated stocks.

Wall Street analysts have given SRAX a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SRAX wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

SRAX saw a decrease in short interest during the month of May. As of May 28th, there was short interest totaling 687,800 shares, a decrease of 35.1% from the May 13th total of 1,060,000 shares. Based on an average daily trading volume, of 718,300 shares, the short-interest ratio is currently 1.0 days. Currently, 3.4% of the shares of the stock are sold short.
View SRAX's Short Interest.

SRAX is scheduled to release its next quarterly earnings announcement on Monday, August 16th 2021.
View our earnings forecast for SRAX.

SRAX, Inc. (NASDAQ:SRAX) released its quarterly earnings results on Monday, May, 24th. The business services provider reported ($0.57) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.44. The business services provider had revenue of $5.44 million for the quarter, compared to analyst estimates of $5.03 million. SRAX had a negative trailing twelve-month return on equity of 84.63% and a negative net margin of 165.90%.
View SRAX's earnings history.

SRAX's stock was trading at $2.52 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SRAX stock has increased by 101.2% and is now trading at $5.07.
View which stocks have been most impacted by COVID-19.

SRAX updated its FY 2021 earnings guidance on Tuesday, June, 15th. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $25 million-27 million, compared to the consensus revenue estimate of $25.90 million.

3 brokerages have issued 12-month price targets for SRAX's shares. Their forecasts range from $7.00 to $10.00. On average, they anticipate SRAX's stock price to reach $8.17 in the next year. This suggests a possible upside of 61.1% from the stock's current price.
View analysts' price targets for SRAX or view top-rated stocks among Wall Street analysts.

Some companies that are related to SRAX include Huntsworth (HNT), MDC Partners (MDCA), The Pebble Group (PEBB), M&C Saatchi (SAA), XLMedia (XLM), Mirriad Advertising (MIRI), ad pepper media International (APM), EQ (EQ), Starco Brands (STCB), The Mission Marketing Group (TMMG), The Mission Group (TMG), AirNet Technology (ANTE), Iconic Labs (ICON), Ocean Outdoor (OOUT) and Snipp Interactive (SPN).
View all of SRAX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other SRAX investors own include TG Therapeutics (TGTX), Zynerba Pharmaceuticals (ZYNE), Lowe's Companies (LOW), Square (SQ), Skyworks Solutions (SWKS), TransEnterix (TRXC), Tesla (TSLA), Vuzix (VUZI), Wells Fargo & Company (WFC) and Advanced Micro Devices (AMD).

SRAX trades on the NASDAQ under the ticker symbol "SRAX."

SRAX's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Intrinsic Edge Capital Management LLC (3.13%), Renaissance Technologies LLC (0.94%), Geode Capital Management LLC (0.51%), Dimensional Fund Advisors LP (0.37%), PEAK6 Investments LLC (0.30%) and NorthRock Partners LLC (0.22%).
View institutional ownership trends for SRAX.

SRAX stock was sold by a variety of institutional investors in the last quarter, including Kestra Advisory Services LLC.
View insider buying and selling activity for SRAX or view top insider-selling stocks.

SRAX stock was bought by a variety of institutional investors in the last quarter, including Intrinsic Edge Capital Management LLC, Renaissance Technologies LLC, PEAK6 Investments LLC, NorthRock Partners LLC, Geode Capital Management LLC, Dimensional Fund Advisors LP, Alpha Paradigm Partners LLC, and Bank of New York Mellon Corp.
View insider buying and selling activity for SRAX or or view top insider-buying stocks.

Shares of SRAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SRAX stock can currently be purchased for approximately $5.07.

SRAX has a market capitalization of $117.55 million and generates $14.65 million in revenue each year. The business services provider earns $-14,700,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis.

SRAX employs 153 workers across the globe.

The official website for SRAX is www.srax.com.

SRAX is headquartered at 456 SEATON STREET, LOS ANGELES CA, 90013.

SRAX's mailing address is 456 SEATON STREET, LOS ANGELES CA, 90013. The business services provider can be reached via phone at 323-694-9800 or via email at [email protected]